Showing results (371-380 of 407) with videos related to

Sort By:
Pageof 41
Breast Cancer Research : BCR|January 10, 2015
Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasisMario Giuliano, Sabrina Herrera, Pavel Christiny, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 24, 2019
A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancerJ Veeraraghavan, C De Angelis, R Mao, et al.
Cancer Research Communications|July 28, 2023
Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor-positive Breast Cancers for Targeted TreatmentBeom-Jun Kim, Ze-Yi Zheng, Jonathan T Lei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2019
Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without ChemotherapyCarmine De Angelis, Chandandeep Nagi, Cliff C Hoyt, et al.
Molecular Cancer Research : MCR|August 18, 2019
Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast CancerVidyalakshmi Sethunath, Huizhong Hu, Carmine De Angelis, et al.
Molecular Cancer Therapeutics|May 23, 2024
PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast CancerAnran Chen, Beom-Jun Kim, Aparna Mitra, et al.
NPJ Breast Cancer|May 1, 2020
BCL9/STAT3 regulation of transcriptional enhancer networks promote DCIS progressionHanan S Elsarraj, Yan Hong, Darlene Limback, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2023
A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast CancerJamunarani Veeraraghavan, Carolina Gutierrez, Carmine De Angelis, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 10, 2014
GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complexBin He, Rainer B Lanz, Warren Fiskus, et al.
Breast Cancer Research and Treatment|November 8, 2017
Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancerMothaffar F Rimawi, Carmine De Angelis, Alejandro Contreras, et al.
Pageof 41